The normobaric oxygen paradox: A novel way to administer oxygen as an adjuvant treatment for cancer?

Medicine and Dentistry

• Vasculotropin 100%
• Malignant Neoplasm 100%
• Cancer Cell 100%
• Hypoxia Inducible Factor 1 100%
• Adjuvant Therapy 100%
• Chemotherapy 50%
• Immune Response 50%
• Programmed Cell Death 50%
• Side Effect 50%
• Tumor Progression 50%
• Gene Control 50%
• Antineoplastic Activity 50%
• Inflammatory Cell 50%
• Tumor Angiogenesis 50%
• Gene Expression 50%
• Cytoprotection 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Vasculotropin 66%
• Hypoxia Inducible Factor 1 66%
• Chemotherapy 33%
• Antitumor Activity 33%
• Tumor Growth 33%
• Side Effect 33%
• Neoplasm 33%
• Cytoprotection 33%